Literature DB >> 11801943

The microbiology of mucopyocele.

I Brook1, E H Frazier.   

Abstract

OBJECTIVE: To evaluate the aerobic and anaerobic microbiology of mucopyocele. STUDY
DESIGN: Retrospective review of clinical and microbiologic records of patients with mucopyocele between June 1982 and September 1997.
METHODS: Aspirates of 36 mucopyocele were processed for aerobic and anaerobic bacteria.
RESULTS: One hundred six bacterial isolates, 42 aerobic and facultatives and 64 anaerobic, were recovered. The predominant aerobic isolates were Staphylococcus aureus (6 isolates), alpha-hemolytic streptococci (6), Hemophilus spp. (5), and Gram-negative bacilli (6). The predominant anaerobes were Peptostreptococcus sp. (22), Prevotella sp. (15), Fusobacterium sp. (5), and Propionibacterium acnes(5). Thirty-three beta-lactamase-producing bacteria were isolated from 23 patients.
CONCLUSIONS: These findings illustrate the polymicrobial aerobic and anaerobic bacteriology of mucopyocele.

Entities:  

Mesh:

Year:  2001        PMID: 11801943     DOI: 10.1097/00005537-200110000-00020

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  4 in total

1.  Frontal Mucocele causing Unilateral Proptosis.

Authors:  E James; A Dutta; H Swami; R Ramakrishnan
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Frontal sinus mucocele with orbital complications: Management by varied surgical approaches.

Authors:  Sushil Kumar Aggarwal; Kranti Bhavana; Amit Keshri; Raj Kumar; Arun Srivastava
Journal:  Asian J Neurosurg       Date:  2012-07

3.  Mucopyocele of the maxillary sinus.

Authors:  Avinash Kshar; Abhijeet Patil; Hemant Umarji; Sonali Kadam
Journal:  Dent Res J (Isfahan)       Date:  2014-01

4.  Burkholderia Cepacia Causes Frontal Mucopyocele with Anterior Cranial Fossa Extension: A Novel Case Report.

Authors:  Athanasios Saratziotis; Claudia Zanotti; Maria Baldovin; Vlatko Prosenikliev; Enzo Emanuelli
Journal:  Iran J Otorhinolaryngol       Date:  2021-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.